Statements (32)
| Predicate | Object |
|---|---|
| gptkbp:instanceOf |
gptkb:drug
|
| gptkbp:activeIngredient |
minoxidil
|
| gptkbp:appliesTo |
scalp
|
| gptkbp:approvedBy |
gptkb:FDA
1988 |
| gptkbp:availableInStrength |
5%
2% |
| gptkbp:availableOn |
gptkb:government_agency
foam |
| gptkbp:brand |
minoxidil
|
| gptkbp:duration |
indefinite for continued effect
|
| gptkbp:effect |
varies by individual
|
| gptkbp:genericAvailable |
yes
|
| https://www.w3.org/2000/01/rdf-schema#label |
Rogaine
|
| gptkbp:legalStatus |
over-the-counter
|
| gptkbp:manufacturer |
gptkb:Johnson_&_Johnson
|
| gptkbp:marketedIn |
gptkb:Australia
gptkb:Canada gptkb:United_Kingdom gptkb:United_States |
| gptkbp:notRecommendedFor |
children
pregnant women |
| gptkbp:originallyDevelopedAs |
antihypertensive drug
|
| gptkbp:prescriptionRequired |
no
|
| gptkbp:routeOfAdministration |
topical
|
| gptkbp:sideEffect |
gptkb:allergic_contact_dermatitis
scalp irritation unwanted facial hair growth |
| gptkbp:usedFor |
hair loss
androgenetic alopecia |
| gptkbp:bfsParent |
gptkb:Upjohn
|
| gptkbp:bfsLayer |
5
|